Christopher B. Granger, MD, FACC, FESC

TITLE

Professor of Medicine, Division of Cardiology Duke University Durham, North Carolina

Will We See a New Paradigm for SPAF? Which Patients Are More Likely to Benefit from FXIa Inhibition ...